EviMed Research Group

EviMed Research Group is a small, private healthcare research and consulting company focused on epidemiology, health services research, outcomes research, and related evidence generation. Available public information indicates that the firm operates as an independent consultancy rather than as a drug developer, with work spanning real-world evidence and healthcare research support. The company appears to be associated with founder Marya D. Zilberberg, a physician-researcher with publications and conference activity in areas including antimicrobial resistance and critical care. Based on the limited public record, EviMed Research Group does not appear to maintain a therapeutic pipeline or proprietary drug platform, and is best characterized as a specialized health research services business.